دورية أكاديمية
أعرض في EDS

Administration of Cinnamon and Lagersroemia speciosa Extract on Lipid Profile of Polycystic Ovarian Syndrome Women with High Body Mass Index.

التفاصيل البيبلوغرافية
العنوان: Administration of Cinnamon and Lagersroemia speciosa Extract on Lipid Profile of Polycystic Ovarian Syndrome Women with High Body Mass Index.
المؤلفون: Permadi W; Department of Obstetrics and Gynecology, RSUP Dr. Hasan Sadikin, Universitas Padjadjaran, Bandung, Indonesia., Hestiantoro A; Department of Obstetrics and Gynecology, RSUPN Cipto Mangunkusumo, University of Indonesia, Depok, Indonesia., Ritonga MA; Department of Obstetrics and Gynecology, RSUP Dr. Hasan Sadikin, Universitas Padjadjaran, Bandung, Indonesia., Ferrina AI; Department of Obstetrics and Gynecology, RSUP Dr. Hasan Sadikin, Universitas Padjadjaran, Bandung, Indonesia., Iswari WA; Department of Obstetrics and Gynecology, RSUP Dr. Hasan Sadikin, Universitas Padjadjaran, Bandung, Indonesia., Sumapraia K; Department of Obstetrics and Gynecology, RSUPN Cipto Mangunkusumo, University of Indonesia, Depok, Indonesia., Muharram R; Department of Obstetrics and Gynecology, RSUPN Cipto Mangunkusumo, University of Indonesia, Depok, Indonesia., Djuwantono T; Department of Obstetrics and Gynecology, RSUP Dr. Hasan Sadikin, Universitas Padjadjaran, Bandung, Indonesia., Wiweko B; Department of Obstetrics and Gynecology, RSUPN Cipto Mangunkusumo, University of Indonesia, Depok, Indonesia., Tjandrawinata R; Division of Molecular Pharmacology, Dexa Laboratories of Biomolecular Sciences, Dexa Medica Group, Jawa Barat, Indonesia.
المصدر: Journal of human reproductive sciences [J Hum Reprod Sci] 2021 Jan-Mar; Vol. 14 (1), pp. 16-20. Date of Electronic Publication: 2021 Mar 30.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 101473512 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0974-1208 (Print) Linking ISSN: 19984766 NLM ISO Abbreviation: J Hum Reprod Sci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Mumbai : Medknow Publications, 2008-
مستخلص: Background: Hyperinsulinemia, a common feature in PCOS, have been found to contribute to metabolic disturbance, such as dyslipidaemia and diabetes mellitus type 2. Oral anti-diabetic medications have been prescribed to alleviate this effect. We sought to fnd whether DLBS3233, an insulin sensitizer, could alleviate dyslipidaemia in women with PCOS with high BMI.
Aim: This study aimed to investigate the effect of DLBS3233, an herbal combination of C burmanii and L spesiosa extract, on lipid profle, insulin resistance, and free testosterone of women with PCOS with high BMI.
Study Setting and Design: This was a controlled trial conducted in Dr. Cipto Mangunkusumo Hospital, Jakarta, and Dr Hasan Sadikin Hospital, Bandung, Indonesia.
Materials and Methods: A controlled trial was conducted on 62 volunteers diagnosed with PCOS according to Rotterdam criteria and exhibited insulin resistance as signifed by HOMA-IR > 2.0; baseline lipid profile (LDL, HDL, Triglyceride and Total cholesterol) and free testosterone concentration were obtained. Participants were given 100 mg of DLBS3233 in the morning, and volunteers were followed up monthly, with laboratory tests conducted at the third and sixth months. Data were analysed through intention-to-treat analysis, separating high BMI (≥25 kg/m2) subjects.
Statistical Analysis: Repeated-measures model.
Results: DLBS3233 improved lipid profle and insulin sensitivity by reducing triglycerides, HOMA-IR, and free testosterone in subjects with high BMI. Limitations and Implications: The current study does not compare the effect of DLBS3233 with a control group. A larger study with a proper control group would have to be conducted to have more conclusive results.
Conclusion: This study showed that DLBS3233 holds promise as a novel therapy to improve lipid profle for women with PCOS.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2021 Journal of Human Reproductive Sciences.)
References: Diabetes. 2008 Jul;57(7):1824-33. (PMID: 18375436)
Int J Gen Med. 2011;4:345-57. (PMID: 21674027)
Phytother Res. 2012 Mar;26(3):317-24. (PMID: 22095937)
Int J Gynaecol Obstet. 2008 Aug;102(2):137-40. (PMID: 18504045)
J Complement Integr Med. 2016 Dec 1;13(4):413-420. (PMID: 27451997)
J Hum Reprod Sci. 2017 Jan-Mar;10(1):31-36. (PMID: 28479753)
J Obstet Gynaecol India. 2012 Oct;62(5):551-6. (PMID: 24082557)
J Nutr. 2001 Sep;131(9):2242-7. (PMID: 11533261)
Lancet. 2004 Jan 10;363(9403):157-63. (PMID: 14726171)
J Clin Endocrinol Metab. 1991 Jan;72(1):83-9. (PMID: 1898744)
Adv Ther. 2012 Sep;29(9):763-74. (PMID: 22932791)
Int J Endocrinol. 2012;2012:571035. (PMID: 22737168)
Int J Reprod Biomed. 2016 Dec;14(12):743-754. (PMID: 28331909)
Int J Mol Sci. 2017 Jun 21;18(6):. (PMID: 28635626)
Hum Reprod. 2003 Aug;18(8):1618-25. (PMID: 12871871)
Arch Gynecol Obstet. 2017 Oct;296(4):661-677. (PMID: 28770353)
Clin Med (Lond). 2016 Jun;16(3):262-6. (PMID: 27251917)
Phytomedicine. 2010 Nov;17(13):1027-32. (PMID: 20554184)
Front Horm Res. 2013;40:83-102. (PMID: 24002407)
Endocr Rev. 2016 Oct;37(5):467-520. (PMID: 27459230)
Int J Reprod Med. 2014;2014:719050. (PMID: 25763405)
Curr Opin Obstet Gynecol. 2010 Dec;22(6):466-76. (PMID: 20724929)
Clin Med Insights Reprod Health. 2019 Sep 09;13:1179558119874042. (PMID: 31523137)
Diabetol Metab Syndr. 2017 Dec 01;9:95. (PMID: 29213336)
Drug Des Devel Ther. 2016 Mar 29;10:1279-89. (PMID: 27099473)
فهرسة مساهمة: Keywords: DLBS3233; high body mass index; polycystic ovarian syndrome
تواريخ الأحداث: Date Created: 20210604 Latest Revision: 20230920
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8057150
DOI: 10.4103/jhrs.JHRS_141_20
PMID: 34083987
قاعدة البيانات: MEDLINE
الوصف
تدمد:0974-1208
DOI:10.4103/jhrs.JHRS_141_20